Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas.

Bhat YJ, Yaseen A, Hassan I.

Indian Dermatol Online J. 2016 Mar-Apr;7(2):124-5. doi: 10.4103/2229-5178.178076. No abstract available.

2.

The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma.

Anjum MZ, Pasha KH, Abbas SH, Zubair M.

Pak J Med Sci. 2016 Jan-Feb;32(1):211-4. doi: 10.12669/pjms.321.6390.

3.

Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial.

Asilian A, Mokhtari F, Kamali AS, Abtahi-Naeini B, Nilforoushzadeh MA, Mostafaie S.

Adv Biomed Res. 2015 Nov 30;4:257. doi: 10.4103/2277-9175.170682. eCollection 2015.

4.

Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.

Ge J, Zheng J, Zhang L, Yuan W, Zhao H.

Sci Rep. 2016 Jan 28;6:19765. doi: 10.1038/srep19765.

5.

Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma.

Bertoni N, Pereira LM, Severino FE, Moura R, Yoshida WB, Reis PP.

BMC Med Genet. 2016 Jan 15;17:4. doi: 10.1186/s12881-015-0262-2.

6.

A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas.

Schultz B, Yao X, Deng Y, Waner M, Spock C, Tom L, Persing J, Narayan D.

PLoS One. 2015 Oct 23;10(10):e0113168. doi: 10.1371/journal.pone.0113168. eCollection 2015. Erratum in: PLoS One. 2015;10(11):e0143806.

7.

Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM.

J Am Acad Dermatol. 2016 Jan;74(1):120-6. doi: 10.1016/j.jaad.2015.08.024. Epub 2015 Oct 19.

PMID:
26494585
8.

Mechanisms of propranolol action in infantile hemangioma.

Kum JJ, Khan ZA.

Dermatoendocrinol. 2015 Jan 26;6(1):e979699. doi: 10.4161/19381980.2014.979699. eCollection 2014 Jan-Dec.

9.

Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.

Li SB, Xu GQ, Gao F, Huo R.

Exp Ther Med. 2015 Jul;10(1):51-54. Epub 2015 May 8.

10.

A survey on clinical use of propranolol for infantile hemangiomas in mainland China.

Chen ZG, Zheng JW, Zhang L, Zhu L, Wang YA.

Int J Clin Exp Med. 2015 Feb 15;8(2):2138-46. eCollection 2015.

11.

Biology of infantile hemangioma.

Itinteang T, Withers AH, Davis PF, Tan ST.

Front Surg. 2014 Sep 25;1:38. doi: 10.3389/fsurg.2014.00038. eCollection 2014. Review.

12.

Novel treatment for infantile hemangiomas.

Korownyk C, Ross D, Fiorillo L.

Can Fam Physician. 2014 Dec;60(12):e590. Review. No abstract available.

13.

Management of infantile hemangiomas: current trends.

Sethuraman G, Yenamandra VK, Gupta V.

J Cutan Aesthet Surg. 2014 Apr;7(2):75-85. doi: 10.4103/0974-2077.138324.

14.

Beta blockers: an innovation in the treatment of infantile hemangiomas.

Admani S, Feldstein S, Gonzalez EM, Friedlander SF.

J Clin Aesthet Dermatol. 2014 Jul;7(7):37-45. Review.

15.

Beta-blockers as therapy for infantile hemangiomas.

Nguyen HP, Pickrell BB, Wright TS.

Semin Plast Surg. 2014 May;28(2):87-90. doi: 10.1055/s-0034-1376259.

16.

A retrospective study to classify surgical indications for infantile hemangiomas.

Lee AH, Hardy KL, Goltsman D, Liou P, Garzon MC, Rohde CH, Wu JK.

J Plast Reconstr Aesthet Surg. 2014 Sep;67(9):1215-21. doi: 10.1016/j.bjps.2014.05.007. Epub 2014 May 16.

17.

Propranolol for infantile haemangiomas: experience from a tertiary center.

Pandey V, Tiwari P, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V.

J Cutan Aesthet Surg. 2014 Jan;7(1):37-41. doi: 10.4103/0974-2077.129975.

18.

Identification of serum regression signs in infantile hemangioma.

D'Arcangelo D, Nicodemi EM, Rossi S, Giampietri C, Facchiano F, Facchiano A.

PLoS One. 2014 Mar 5;9(3):e88545. doi: 10.1371/journal.pone.0088545. eCollection 2014.

19.

Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches.

Mulligan PR, Prajapati HJ, Martin LG, Patel TH.

Br J Radiol. 2014 Mar;87(1035):20130392. doi: 10.1259/bjr.20130392. Review.

20.

Signaling pathways in the development of infantile hemangioma.

Ji Y, Chen S, Li K, Li L, Xu C, Xiang B.

J Hematol Oncol. 2014 Jan 31;7:13. doi: 10.1186/1756-8722-7-13. Review.

Items per page

Supplemental Content

Write to the Help Desk